| NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP A Lucena-Cacace, D Otero-Albiol, MP Jiménez-García, S Muñoz-Galvan, ... Clinical Cancer Research 24 (5), 1202-1215, 2018 | 127 | 2018 |
| NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis A Lucena-Cacace, D Otero-Albiol, MP Jiménez-García, ... Oncotarget 8 (59), 99514, 2017 | 73 | 2017 |
| The cargo protein MAP17 (PDZK1IP1) regulates the cancer stem cell pool activating the Notch pathway by abducting NUMB JM Garcia-Heredia, A Lucena-Cacace, EM Verdugo-Sivianes, M Pérez, ... Clinical Cancer Research 23 (14), 3871-3883, 2017 | 63 | 2017 |
| Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy JM García-Heredia, EMV Sivianes, A Lucena-Cacace, S Molina-Pinelo, ... Oncotarget 7 (39), 63611, 2016 | 50 | 2016 |
| MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival M Perez, JM Praena-Fernandez, B Felipe-Abrio, MA Lopez-Garcia, ... PLoS One 8 (2), e56169, 2013 | 50 | 2013 |
| Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment S Muñoz-Galván, A Lucena-Cacace, M Perez, D Otero-Albiol, ... Oncogene 38 (8), 1309-1323, 2019 | 42 | 2019 |
| Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src M Perez, A Lucena-Cacace, LM Marín-Gómez, J Padillo-Ruiz, ... Oncotarget 7 (22), 33111, 2016 | 42 | 2016 |
| ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes K Miki, K Deguchi, M Nakanishi-Koakutsu, A Lucena-Cacace, S Kondo, ... Nature Communications 12 (1), 3596, 2021 | 40 | 2021 |
| NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance A Lucena-Cacace, M Umeda, LE Navas, A Carnero Frontiers in oncology 9, 292, 2019 | 35 | 2019 |
| The role of PIM1/PIM2 kinases in tumors of the male reproductive system MP Jiménez-García, A Lucena-Cacace, MJ Robles-Frías, ... Scientific reports 6 (1), 38079, 2016 | 32 | 2016 |
| Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus MP Jiménez-García, A Lucena-Cacace, MJ Robles-Frías, I Ferrer, ... Oncotarget 8 (35), 58872, 2017 | 31 | 2017 |
| Characterization of hiPSC-derived muscle progenitors reveals distinctive markers for myogenic cell purification toward cell therapy M Nalbandian, M Zhao, M Sasaki-Honda, T Jonouchi, A Lucena-Cacace, ... Stem cell reports 16 (4), 883-898, 2021 | 25 | 2021 |
| Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma P Estevez-Garcia, I Lopez-Calderero, S Molina-Pinelo, S Munoz-Galvan, ... Clinical Cancer Research 19 (14), 3925-3935, 2013 | 21 | 2013 |
| Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2 MP Jimenez-García, A Lucena-Cacace, D Otero-Albiol, A Carnero Cell Death & Disease 12 (6), 515, 2021 | 12 | 2021 |
| Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting Y Tsujisaka, T Hatani, C Okubo, R Ito, A Kimura, M Narita, ... Stem Cell Reports 17 (7), 1772-1785, 2022 | 9 | 2022 |
| Nicotinamide adenine dinucleotide+ metabolism biomarkers in malignant gliomas M Jiménez-García, E Verdugo-Sivianes, A Lucena-Cacace Cancer Translational Medicine 2 (6), 2016 | 7 | 2016 |
| CDH18 is a fetal epicardial biomarker regulating differentiation towards vascular smooth muscle cells J Junghof, Y Kogure, T Yu, EM Verdugo-Sivianes, M Narita, ... NPJ Regenerative Medicine 7 (1), 14, 2022 | 6 | 2022 |
| Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis MP Jimenez-García, A Lucena-Cacace, D Otero-Albiol, A Carnero Journal of Experimental & Clinical Cancer Research 40 (1), 247, 2021 | 6 | 2021 |
| Nicotinamide phosphoribosyltransferase: Biology, role in cancer, and novel drug target A Lucena-Cacace, A Carnero Cancer Translational Medicine 4 (4), 109-116, 2018 | 6 | 2018 |
| Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids Y Tian, Y Tsujisaka, VY Li, K Tani, A Lucena-Cacace, Y Yoshida Frontiers in Cell and Developmental Biology 10, 1001453, 2022 | 5 | 2022 |
Daniel Otero-AlbiolInstituto de Biomedicina de SevillaVerified email at us.es
